Clinical Trials Browser

Completed × NETWORK × Hydatidiform Mole × Clear all

NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

Phase 3 Completed

57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole

NCT00003702 2018-05-15

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

Phase 3 Completed

240 enrolled 9 charts

Hydatidiform Mole

NCT00521118 2017-08-24

Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors

Phase 2 Completed

Hydatidiform Mole

NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

Phase 3 Completed

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease